Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer

by Ianza, Anna, Sirico, Marianna, Bernocchi, Ottavia, Generali, Daniele
Published in Front Cell Dev Biol (2021)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

by Sobhani, Navid, Ianza, Anna, D’Angelo, Alberto, Roviello, Giandomenico, Giudici, Fabiola, Bortul, Marina, Zanconati, Fabrizio, Bottin, Cristina, Generali, Daniele
Published in Cells (2018)

EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience

by Ianza, Anna, Di Chicco, A., Biagi, C., Giudici, F., Dicorato, A., Guglielmi, A., Variola, F., Tomasi, S., Roviello, G., Generali, D., Zanconati, F.
Published in J Cancer Res Clin Oncol (2021)

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer

by Roviello, Giandomenico, Ramello, Monica, Catalano, Martina, D’Angelo, Alberto, Conca, Raffaele, Gasperoni, Silvia, Dreoni, Lorenzo, Petrioli, Roberto, Ianza, Anna, Nobili, Stefania, Aieta, Michele, Mini, Enrico
Published in Sci Rep (2020)

Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study

by Schettini, Francesco, Sobhani, Navid, Ianza, Anna, Triulzi, Tiziana, Molteni, Alfredo, Lazzari, Maria Chiara, Strina, Carla, Milani, Manuela, Corona, Silvia Paola, Sirico, Marianna, Bernocchi, Ottavia, Giudici, Fabiola, Cappelletti, Maria Rosaria, Ciruelos, Eva, Jerusalem, Guy, Loi, Sherine, Fox, Stephen B., Generali, Daniele
Published in Breast Cancer Res Treat (2020)